A pain relief item enclosed by two dissimilar products. The combination is then surrounded by top and bottom cover and when placed near the body will relieve pain.
Pain relief has long been known to be a challenge through-out the world. Many areas of medicine are using chemicals and a diversity of electrical impulse devices. Some others use laser and LED devices. Opioids have become very dangerous to many patients.
There was a demonstration by some scientists who had demonstrated a cross-polymer of sorts which caused pain relief.
PVDF is used in many industries all over the world. The general uses in medicine are limited to Western Blotting. As a membrane, it is used in repair of veins and heart muscle tissue. For example, as a sensor it is used in sleep disorder studies to monitor air flow of patients.
There is no device at the present time of a pain relief device which can last a 15-20 year duration without breakdown that is not ingested to be penetrated into the human body. Most interesting with this invention, no direct skin contact is required and most important no wires, no batteries and it is very portable.
The invention uses PVDF film as resonator of low reverberation of the body tissue energy. It is believed that a regeneration of cells occurs, thereby relieving pain.
The materials are combined and packaged in a way as to best utilize the potential of the PVDF film. In this manner a more precise and better pain relief takes place.
The invention is non-invasive to the body and drug free.
Other advantages are that materials can be packaged to meet any configuration other than enclosing it into a metallic seal.
Additional advantages of the present invention will be readily appreciated, as the same becomes better understood by reference to the following detailed description when considered in connection with the accompanying drawings wherein:
The top and bottom covers can be of any material other than metallic in composition. The invention can be surrounded by laminating or bound in two pieces of sports tape. It may also be incorporated into other wellness products to help accelerate relief or healing.
The copper tape acts as a reflective shield against loss of film activity away from the body. Copper is also an enhancement to the invention in that it is also a generator of resonance.
Copper and silver are both noble metals which both have an extra electron in the outer orbit, thus e-spin/plasmon resonance exists. The latter is the cause of resonance with the body.
The PVDF used in this invention is preferably silver doped.
The polarizer polymer is used to make this resonance more effective when being used.
The total sealing of the copper tape/PVDF film/polarizer become one integrated item. As previously shown the coverings may be made of any material other than metallic materials. The coverings must be less than 1/16th inch thick. During the process of sealing the temperature must not exceed 130 degrees F. It is preferred that the covering is flexible to conform against the surface of the body to which it is applied, although some stiffness in the credit card sized package is manageable for use in relief of headaches and other inflammatory pain.
The PVDF film is very critical due to its functional properties as related to cellular body tissue.
These properties are as follows:
The unique function of PVDF makes it suitable for the purpose of pain relief and possibly long term relief.
Direct skin contact, if available, is probably best, but not required. The field of affect ranges from direct skin contact to approximately ¾″ to 1″ to have positive results based on evidence to date.
Using the item through clothing is fine due to the physical affects which are the nature of the invention, and it is still functional. It is believed that both of the above methods were conclusive as to efficacy with positive results in each.
When the invention is used near the body, cellular frequencies are projected out and PVDF film with high sensitivity becomes more active, thus causing positive frequency feedback.
The frequencies exchanged in this manner signal to the cells which are in dysfunction that there is new energy available to regenerate themselves.
Dr. K. Meyl (THE NEW TESLA) in his analysis of the new physics proves that the energy fields transmitted in nature are scalar waves/vortex. He also proves in biology that this type of energy/frequency is the functional basis of cellular communication.
Scalar waves are a combination of electrical energy and electromagnetic wave propagation.
Based on this new science which has been and is being proven more and more world-wide today, the total functionality of PVDF in the invention is very similar to this physics. Now we can understand why it is effective in human tissue regeneration to help relieve pain.
Once the three components copper tape 10 (¾″×2″ as shown), polarizer 12 (⅓″×1¾″ as shown), and PVDF film 14 (⅓″×1¾″ as shown) are bound together as ITEM A, it may be used in a number of different ways as demonstrated in the following pictures. For all the samples the ITEM A has been ghosted. In actual use the ITEM A is preferred to be enclosed without visual detection such as the cover or enclosure in
If the polarizer 12 is disposed on only one side of PVDF film 14, then there will be directionality to the device wherein the side of the device having the polarizer would be the side that would face the body (toward the skin) as set forth in
An alternative to ITEM A would be ITEM B as shown in
Due to the fact that ITEM A or ITEM B is flexible, it can be used any wellness or therapeutic application where inflammatory pain is involved.
Following examples show our present configuration of ITEM A sealed in a laminate.
With new location designs such as pocketing of ITEM A once sealed, we are looking at simple and convenient ways of using this invention.
The device can also improve current items which entail wellness healing.
With a red laser light therapy product 100, the device of the present invention is able to cut usage times required by manufacturers of red laser therapy devices (pulsed or non-pulsed) down by at least half the amount of time. So half the time is required with ITEM A or ITEM B embedded into or otherwise attached to the light therapy device where the laser is directed through the ITEM A or ITEM B as shown in
In using this invention the time required near body application are as follows: For headaches approximately 30-60 seconds. Other aches use in inflammatory pain area for about 2-5 minutes. More severe inflammatory pain may take 20 to 30 minutes. For continuous use, 6-8 hours may relieve severe pain within this time frame.
Many modifications and variations of the present invention are possible in light of the above teachings. The invention may be practiced otherwise than as specifically described within the scope of the novelty set forth in description of the subject invention.
The subject application is a divisional application of U.S. Nonprovisional patent application Ser. No. 15/599,822 filed on May 19, 2017, which claims priority to and the benefit of U.S. Provisional Patent Application No. 62/339,570, filed on May 20, 2017, the entire contents of which are hereby incorporated by reference.
Number | Name | Date | Kind |
---|---|---|---|
4906849 | Duo et al. | Mar 1990 | A |
5487739 | Aebischer et al. | Jan 1996 | A |
6179826 | Aebischer et al. | Jan 2001 | B1 |
6455140 | Whitney et al. | Sep 2002 | B1 |
6475609 | Whitney et al. | Nov 2002 | B1 |
6628989 | Penner et al. | Sep 2003 | B1 |
6942634 | Odland | Sep 2005 | B2 |
7283874 | Penner | Oct 2007 | B2 |
7424325 | Koller et al. | Sep 2008 | B2 |
7812025 | Matsumoto et al. | Oct 2010 | B2 |
7883535 | Cantin et al. | Feb 2011 | B2 |
7930031 | Penner | Apr 2011 | B2 |
7947270 | Franklin | May 2011 | B2 |
7951831 | Hammock et al. | May 2011 | B2 |
7952349 | Huang et al. | May 2011 | B2 |
8088163 | Kleiner | Jan 2012 | B1 |
8277510 | Kleiner | Oct 2012 | B2 |
8292960 | Kleiner | Oct 2012 | B2 |
8337485 | Ludlow et al. | Dec 2012 | B2 |
8343189 | Assell et al. | Jan 2013 | B2 |
8343536 | Bates et al. | Jan 2013 | B2 |
8557163 | Chian et al. | Oct 2013 | B2 |
8574146 | Gillespie, Jr. et al. | Nov 2013 | B2 |
8577460 | Penner | Nov 2013 | B2 |
8708701 | Levens et al. | Apr 2014 | B2 |
8715355 | Kleiner | May 2014 | B2 |
8721520 | Caira et al. | May 2014 | B2 |
8758798 | Stopek et al. | Jun 2014 | B2 |
8758799 | Stopek et al. | Jun 2014 | B2 |
8758800 | Stopek et al. | Jun 2014 | B2 |
8808305 | Kleiner | Aug 2014 | B2 |
8883218 | Radominiska-Pandya et al. | Nov 2014 | B2 |
8896211 | Tomer et al. | Nov 2014 | B2 |
8934972 | Penner | Jan 2015 | B2 |
8980302 | Stopek et al. | Mar 2015 | B2 |
9011754 | Leong et al. | Apr 2015 | B2 |
9044209 | Dayton et al. | Jun 2015 | B2 |
9044397 | Choi et al. | Jun 2015 | B2 |
9050265 | Jamison et al. | Jun 2015 | B2 |
9057068 | de la Chapelle et al. | Jun 2015 | B1 |
9271824 | Ludlow et al. | Mar 2016 | B2 |
9314618 | Imran et al. | Apr 2016 | B2 |
20040011685 | Lux et al. | Jan 2004 | A1 |
Number | Date | Country |
---|---|---|
WO-2014022049 | Feb 2014 | WO |
Entry |
---|
Eccles (The Journal of Alternative and Complementary Medician, vol. 11, No. 2, A Critical Review of Randomized Controlled Trials of Static Magnets for Pain Relief) (Year: 2005). |
Number | Date | Country | |
---|---|---|---|
20200246457 A1 | Aug 2020 | US |
Number | Date | Country | |
---|---|---|---|
62339570 | May 2016 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15599822 | May 2017 | US |
Child | 16779754 | US |